HIV Cepheid Nabs CE Mark for PCR-Based HIV-1 Tests Both tests run on any of the firm's GeneXpert systems and add second targets for HIV detection and early identification. Altona Diagnostics Nabs CE Mark for HIV-1 Viral Load PCR Assay The firm's assay leverages reverse transcriptase quantitative PCR to amplify two separate regions of the HIV-1 genome to monitor HIV-infected patients. Roche Cobas HIV, Hepatitis C Tests Nab WHO Prequalification Prequalification from the World Health Organization indicates that products meet high quality standards and are safe for their intended use. OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate The firm attributed its quarterly and annual revenue gains primarily to sales of COVID-19 testing sample collection devices. Hologic Receives Additional FDA Approval for Diagnostic Use of HIV-1 Viral Load Test The company said that its Aptima HIV-1 molecular test utilizes a dual-target approach against highly conserved regions in the HIV genome. Sep 14, 2020 Hologic Gets WHO Prequalification Approval for HIV Assay, Offers $950M in Senior Notes Sep 1, 2020 Roche Receives FDA Approval for HIV-1/HIV-2 Qualitative Molecular Test Aug 5, 2020 OraSure Technologies Q2 Revenues Drop 25 Percent, Miss Analysts Estimates Aug 3, 2020 Cervical Cancer Study in Ugandan Women Finds HPV-Specific Tumor DNA Methylation, Gene Expression Jun 15, 2020 NeuMoDx Molecular Nabs CE Mark for HIV Viral Load Assay May 19, 2020 Advanced Biological Laboratories Gets CE-IVD Mark for HIV Genotyping Assays May 7, 2020 Grifols ART System Nabs FDA Approval May 6, 2020 OraSure Technologies Q1 Revenues Rise 5 Percent Apr 29, 2020 Broad Institute Researchers Develop Viral Detection Platform Based on Microfluidics, CRISPR Tech Mar 27, 2020 New Method for Detecting Point Mutations Could Significantly Impact Low-Cost Diagnostics Premium Mar 12, 2020 Jury Rules in Favor of Hologic, Grifols in BioMérieux Patent Infringement Lawsuit Feb 19, 2020 OraSure Technologies Q4 Revenues Down 1 Percent Jan 30, 2020 Roche Diagnostics Keeps Eyes Firmly on China Premium Jan 29, 2020 Hologic Fiscal Q1 Diagnostics Revenues Rise 5 Percent Dec 3, 2019 Co-Diagnostics Joint Venture Gets Clearance in India for Five MDx Tests Nov 7, 2019 OraSure Strives for End-to-End Presence in Microbiome Market with Diversigen Buy Premium Nov 6, 2019 OraSure Q3 Revenues Fall 22 Percent; Firm Announces $12M All-Cash Buy of Diversigen Nov 5, 2019 FDA Authorizes Marketing of Vela Diagnostics NGS-Based HIV-1 Drug Resistance Mutation Test Oct 31, 2019 Sherlock Biosciences Aims to Create Dx Tool for 'Where Testing Should be Done, But Isn't' Premium Oct 15, 2019 Enzo Biochem Fiscal Q4 Revenues Down 8 Percent Load More Breaking News 23andMe to Acquire Telemedicine Platform Company Lemonaid Health for $400M in Cash, Stock UK Biobank Study Investigates Incomplete Penetrance of Mendelian Disease Variants MDxHealth Q3 Revenues Grow 23 Percent BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates The Scan Guidelines for Ancient DNA Work More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature. And Cleared A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times. Suit Over Allegations The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director. Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.